HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$3.93
Day range
$3.81 - $3.95
Year range
$2.56 - $6.12
Market cap
41.36M USD
Avg Volume
138.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.65M | -13.99% |
Net income | -4.33M | 12.67% |
Net profit margin | — | — |
Earnings per share | -0.40 | — |
EBITDA | -4.65M | 14.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.90M | -52.19% |
Total assets | 17.42M | -51.05% |
Total liabilities | 4.90M | 5.21% |
Total equity | 12.52M | — |
Shares outstanding | 10.80M | — |
Price to book | 3.39 | — |
Return on assets | -60.39% | — |
Return on capital | -78.48% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.33M | 12.67% |
Cash from operations | -3.94M | 24.15% |
Cash from investing | 3.59M | 1,878.24% |
Cash from financing | — | — |
Net change in cash | -316.19K | 94.12% |
Free cash flow | -2.26M | 35.37% |
About
Founded
2013
Headquarters
Website
Employees
24
